These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5693428)

  • 1. [Clinical use of Ugarone capsules (urogastrone)].
    Fujiwara M; Kawashima M
    Naika Hokan; 1968 Apr; 15(4):117-20. PubMed ID: 5693428
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dimedrol in the complex therapy of patients with peptic ulcer and chronic gastritis].
    Smoligovets PV
    Vrach Delo; 1966 Mar; 3():22-5. PubMed ID: 5990029
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urogastrone therapy in gastroduodenal ulcer].
    Babando GM
    Minerva Gastroenterol; 1970; 16(4):171-80. PubMed ID: 5516914
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of adrenergic substances on the acid and alkaline secretion of the stomach].
    Anshelevich YuV ; Okun KV
    Ter Arkh; 1972 Oct; 44(10):47-9. PubMed ID: 4144669
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical use of a gastrin-like synthetic peptide, tetragastrin].
    Tsunashima K; Sato Y; Osada S; Abe M; Oshita Y
    Horumon To Rinsho; 1971 Apr; 19(4):311-6. PubMed ID: 5165112
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trial of R. 306 in gastric pathology].
    Kressmann P; Levrat R; Girard M
    J Med Lyon; 1969 May; 50(165):869-70 passim. PubMed ID: 5399269
    [No Abstract]   [Full Text] [Related]  

  • 7. [Glycopeptide sulfate in the treatment of gastritis and of gastric and duodenal ulcers].
    Buonincontro A; Confetto V; Atelli A; Foglia M; Ferrara G; Romano E
    Minerva Gastroenterol; 1975; 21(4):266-76. PubMed ID: 1228499
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of the stomach ulcer, duodenal ulcer and gastritis in the country practice].
    Gehramann U
    Landarzt; 1968 Aug; 44(24):1162-4. PubMed ID: 5702795
    [No Abstract]   [Full Text] [Related]  

  • 9. [Stomach-protective treatment with Phosphalugel in stomach and duodenal diseases].
    Heide M
    Ther Ggw; 1964 Dec; 103(12):1560-73. PubMed ID: 5827732
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gastritis, stomach ulcer, reflux diseases. Motility effective therapy with Motilium].
    Heinkelein J
    ZFA (Stuttgart); 1982 Jun; 58(18):1028-30. PubMed ID: 7113397
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tibon tolerance in patients with tuberculosis and concomitant peptic ulcer and chronic gastritis].
    Petrenko VM
    Vrach Delo; 1976 Dec; (12):107-11. PubMed ID: 1014572
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antacid effect of a magnesium trisilicate-1-hyoscyamine combination preparation (Neoplex B)--clinical and function analytical studies].
    Piaty R
    Wien Med Wochenschr; 1968 Feb; 118(8):157-9. PubMed ID: 4301560
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of patients with duodenal and gastric ulcers by Undorosvsk mineral waters].
    Chuchkalov EM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1966; 31(4):301-7. PubMed ID: 5988796
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood viscosity indicators in patients with gastric and duodenal diseases].
    Murashko VV; Zhuravlev AK; Shylle ChI; Shabashova NI; Skliarova MA
    Ter Arkh; 1985; 57(2):31-4. PubMed ID: 4002132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Observations on the therapeutic modification of various gastric disorders with a new combined action agent "Antul"].
    Theinl K
    Wien Med Wochenschr; 1966 Dec; 116(49):1086-8. PubMed ID: 5973405
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of the maximum acid output of the stomach by isopropamide iodide ('Tyrimide').
    Jones CT; Troughton WD
    N Z Med J; 1966 Nov; 65(411):758-60. PubMed ID: 4381047
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of pirenzepine in peptic ulcer and in non ulcerous gastroduodenal diseases. A multicentre controlled clinical trial.
    Giorgi-Conciato M; Daniotti S; Ferrari PA; Gaetani M; Petrin G; Sala P; Valentini P
    Scand J Gastroenterol Suppl; 1982; 81():1-41. PubMed ID: 6221398
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the gastric secretion inhibitory substance in human saliva (Salivogastrone). II. Clinical study.
    Miyoshi A; Moriga M; Hirano S; Kobayashi M; Suyama T
    Naika Hokan; 1969 Aug; 16(8):319-34. PubMed ID: 4242609
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the symptomatic clinical efficacy of ranitidine in benign gastroduodenal pathology].
    Rizzi B; Villa E; Di Sclafani E; Terni E; Proserpio L; Bonfanti R; Komla-Ebri K
    Clin Ter; 1985 Jun; 113(6):447-55. PubMed ID: 4028651
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contribution to conservative treatment of gastritis, stomach ulcer and duodenal ulcer].
    Zydek K
    Med Monatsschr; 1969 Apr; 23(4):182-4. PubMed ID: 5801517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.